First Trust Nasdaq Pharmaceuticals ETF $FTXH Shares Bought by LPL Financial LLC

LPL Financial LLC raised its position in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) by 87.7% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 104,902 shares of the company’s stock after purchasing an additional 49,026 shares during the quarter. LPL Financial LLC owned about 19.07% of First Trust Nasdaq Pharmaceuticals ETF worth $2,884,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Cambridge Investment Research Advisors Inc. lifted its holdings in shares of First Trust Nasdaq Pharmaceuticals ETF by 19.2% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 16,567 shares of the company’s stock worth $455,000 after acquiring an additional 2,663 shares during the last quarter. NBC Securities Inc. increased its stake in First Trust Nasdaq Pharmaceuticals ETF by 21,400.0% during the 1st quarter. NBC Securities Inc. now owns 1,075 shares of the company’s stock worth $29,000 after buying an additional 1,070 shares during the period. Envestnet Asset Management Inc. increased its stake in First Trust Nasdaq Pharmaceuticals ETF by 17.0% during the 4th quarter. Envestnet Asset Management Inc. now owns 16,403 shares of the company’s stock worth $442,000 after buying an additional 2,384 shares during the period. Summit Investment Advisors Inc. increased its stake in First Trust Nasdaq Pharmaceuticals ETF by 13.0% during the 4th quarter. Summit Investment Advisors Inc. now owns 14,173 shares of the company’s stock worth $382,000 after buying an additional 1,633 shares during the period. Finally, Vivaldi Capital Management LP increased its stake in First Trust Nasdaq Pharmaceuticals ETF by 15.6% during the 4th quarter. Vivaldi Capital Management LP now owns 8,677 shares of the company’s stock worth $243,000 after buying an additional 1,171 shares during the period.

First Trust Nasdaq Pharmaceuticals ETF Stock Up 0.5%

Shares of FTXH opened at $27.50 on Monday. First Trust Nasdaq Pharmaceuticals ETF has a fifty-two week low of $23.28 and a fifty-two week high of $29.72. The firm’s 50 day moving average price is $26.27 and its 200 day moving average price is $26.32. The company has a market cap of $15.12 million, a P/E ratio of 14.51 and a beta of 0.70.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, June 30th. Investors of record on Thursday, June 26th were paid a dividend of $0.0892 per share. This represents a $0.36 annualized dividend and a yield of 1.3%. The ex-dividend date of this dividend was Thursday, June 26th.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.